These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16340333)

  • 1. Neurocysticercosis: evaluation with advanced magnetic resonance techniques and atypical forms.
    do Amaral LL; Ferreira RM; da Rocha AJ; Ferreira NP
    Top Magn Reson Imaging; 2005 Apr; 16(2):127-44. PubMed ID: 16340333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ununsual manifestations of neurocysticercosis in MR imaging: analysis of 172 cases.
    Amaral L; Maschietto M; Maschietto R; Cury R; Ferreira NF; Mendonça R; Lima SS
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):533-41. PubMed ID: 14513153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of neurocysticercosis.
    Lerner A; Shiroishi MS; Zee CS; Law M; Go JL
    Neuroimaging Clin N Am; 2012 Nov; 22(4):659-76. PubMed ID: 23122261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical Presentations of Extraparenchymal Neurocysticercosis.
    Fan J; Tang R; Zhang L; Hoang PT; Ayoade F; Diaz-Perez JA; Moss HE; Jiang H
    J Neuroophthalmol; 2023 Sep; 43(3):370-375. PubMed ID: 36637411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive MR cisternography with fluid-attenuated inversion recovery and 100% supplemental O(2) in the evaluation of neurocysticercosis.
    Braga F; Rocha AJ; Gomes HR; Filho GH; Silva CJ; Fonseca RB
    AJNR Am J Neuroradiol; 2004 Feb; 25(2):295-7. PubMed ID: 14970035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of 3D magnetic resonance imaging sequences in diagnosing basal subarachnoid neurocysticercosis.
    Carrillo Mezo R; Lara García J; Arroyo M; Fleury A
    Acta Trop; 2015 Dec; 152():60-65. PubMed ID: 26327445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of intraventricular cysticercosis by magnetic resonance imaging: improved detection with three-dimensional spoiled gradient recalled echo sequences.
    Robbani I; Razdan S; Pandita KK
    Australas Radiol; 2004 Jun; 48(2):237-9. PubMed ID: 15230764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal neurocysticercosis.
    Alsina GA; Johnson JP; McBride DQ; Rhoten PR; Mehringer CM; Stokes JK
    Neurosurg Focus; 2002 Jun; 12(6):e8. PubMed ID: 15926787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocysticercosis: a review of current status and management.
    Sinha S; Sharma BS
    J Clin Neurosci; 2009 Jul; 16(7):867-76. PubMed ID: 19394828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiologic manifestations of intraventricular and subarachnoid racemose neurocysticercosis.
    Hauptman JS; Hinrichs C; Mele C; Lee HJ
    Emerg Radiol; 2005 Apr; 11(3):153-7. PubMed ID: 16028320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequency of spinal involvement in patients with basal subarachnoid neurocysticercosis.
    Callacondo D; Garcia HH; Gonzales I; Escalante D; Nash TE;
    Neurology; 2012 May; 78(18):1394-400. PubMed ID: 22517102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rare case of racemose neurocysticercosis and its complications. Case report.
    Pamplona J; Braz A; Conceição C; Rios C; Reis J
    Neuroradiol J; 2015 Aug; 28(4):418-20. PubMed ID: 26416817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT and MR imaging of neurocysticercosis.
    Noujaim SE; Rossi MD; Rao SK; Cacciarelli AA; Mendonca RA; Wang AM; Coelho FH
    AJR Am J Roentgenol; 1999 Dec; 173(6):1485-90. PubMed ID: 10584787
    [No Abstract]   [Full Text] [Related]  

  • 14. Intrathecal gadodiamide for identifying subarachnoid and ventricular neurocysticercosis.
    Higuera-Calleja J; Góngora-Rivera F; Soto-Hernández JL; Del-Brutto OH; Moreno-Andrade T; Gutiérrez-Alvarado R; Rodríguez-Carbajal J
    Trop Med Int Health; 2015 Jul; 20(7):930-3. PubMed ID: 25726723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the association of neurocysticercosis and mesial temporal lobe epilepsy and its impact on the surgical treatment of patients with drug-resistant epilepsy.
    Bianchin MM; Velasco TR; Wichert-Ana L; Dos Santos AC; Sakamoto AC
    Epilepsy Behav; 2017 Nov; 76():168-177. PubMed ID: 28462844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent primary spinal subarachnoid neurocysticercosis.
    Jang JW; Lee JK; Lee JH; Seo BR; Kim SH
    Spine (Phila Pa 1976); 2010 Mar; 35(5):E172-5. PubMed ID: 20118838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleomorphism of the clinical manifestations of neurocysticercosis.
    Patel R; Jha S; Yadav RK
    Trans R Soc Trop Med Hyg; 2006 Feb; 100(2):134-41. PubMed ID: 16214195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging features and surgery-related outcomes in intraventricular neurocysticercosis.
    Citow JS; Johnson JP; McBride DQ; Ammirati M
    Neurosurg Focus; 2002 Jun; 12(6):e6. PubMed ID: 15926785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of 3D volumetric MR sequences in diagnosing intraventricular neurocysticercosis: preliminar results.
    Mont'Alverne Filho FE; Machado Ldos R; Lucato LT; Leite CC
    Arq Neuropsiquiatr; 2011 Feb; 69(1):74-8. PubMed ID: 21359427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistent neurocysticercosis and Japanese B encephalitis: MR imaging correlation.
    Singh P; Kalra N; Ratho RK; Shankar S; Khandelwal N; Suri S
    AJNR Am J Neuroradiol; 2001; 22(6):1131-6. PubMed ID: 11415909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.